default author photo

Takeo Tanaka

Kanazawa University - Department of Endocrinology and Metabolism

Kanazawa

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

61

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Sodium-Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized, Open-Label Trial Study

Number of pages: 32 Posted: 06 Sep 2021
Kanazawa University - Department of Endocrinology and Metabolism, Kanazawa University - Department of Gastroenterology, Kanazawa University - Department of Human Pathology, Kanazawa University - Department of Endocrinology and Metabolism, Kanazawa University - Department of Gastroenterology, Kanazawa University - Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University - Department of Endocrinology and Metabolism, Kanazawa University - Department of Endocrinology and Metabolism, Kanazawa University - Department of Endocrinology and Metabolism, Kanazawa University - Department of Gastroenterology, Kanazawa University - Department of Gastroenterology, Kanazawa University - Department of Gastroenterology, Kanazawa University - Department of Gastroenterology, Kanazawa University - Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University - Department of Gastroenterology and Kanazawa University - Department of Endocrinology and Metabolism
Downloads 61 (951,658)

Abstract:

Loading...

Nonalcoholic fatty liver disease, sodium-glucose cotransporter 2 inhibitors, sulfonylureas, liver histologic scores, hepatic expression of the genes